Decreased vasodilation induced by a new nitric oxide donor in two kidney, one clip hypertensive rats is due to impaired K+ channel activation

被引:38
作者
Bonaventura, D [1 ]
Oliveira, FS [1 ]
da Silva, RS [1 ]
Bendhack, LM [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Farmacol Lab, BR-14040903 Ribeirao Preto, SP, Brazil
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2005年 / 32卷 / 5-6期
关键词
cGMP; K+ channels; nitric oxide donor; renovascular hypertension; vascular smooth muscle;
D O I
10.1111/j.1440-1681.2005.04215.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. We studied the effect of the new compound trans-[RuCl([15]aneN(4))NO](2+) (15-ane) in denuded aortic rings of two kidney (2K) normotensive and two kidney, one clip (2K-1C) hypertensive rats. 2. The compound 15-ane releases nitric oxide (NO) when reduced by a catecholamine (noradrenaline). 3. Oxyhemoglobin (HbO(2)), an NO scavenger, completely abolished the effect of 15-ane in both 2K and 2K-1C rats, indicating that the relaxation is really due to NO release. 4. We tested the hypothesis that an impairment of K+ channels plays an important role in the vasodilation induced by 15-ane. 5. The selective inhibitor of soluble guanylyl-cyclase, namely 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ; 1 mu mol/L) reduced the relaxation induced by 15-ane. In 2K-1C rat aortic rings, ODQ reduced the maximum effect (E-max) of 15-ane, whereas in 2K rat aortic rings ODQ reduced E-max and pD(2) values to 15-ane. 6. The selective K+ channel blockers glibenclamide (blocks K-ATP; 3 mu mol/L), 4-aminopyridine (blocks K-V; 1 mmol/L) and the small conductance K-Ca channel blocker apamin (1 mu mol/L) reduced E-max and pD(2) values for 15-ane-induced relaxation responses of aortas from 2K rats. However, iberiotoxin, a blocker of large conductance K-Ca channels, reduced only the E-max to 15-ane. None of these K+ channel blockers had any effect on the relaxation induced by 15-ane of aortas from 2K-1C rats. 7. These data indicate that an impaired functional activity of K+ channels contributes to the deficient relaxation induced by the NO donor 15-ane in renal hypertensive 2K-1C rat aortas.
引用
收藏
页码:478 / 481
页数:4
相关论文
共 28 条
[1]  
ANGUS JA, 1992, KIDNEY INT, V41, pS73
[2]   NITRIC-OXIDE AND CGMP CAUSE VASORELAXATION BY ACTIVATION OF A CHARYBDOTOXIN-SENSITIVE K-CHANNEL BY CGMP-DEPENDENT PROTEIN-KINASE [J].
ARCHER, SL ;
HUANG, JMC ;
HAMPL, V ;
NELSON, DP ;
SHULTZ, PJ ;
WEIR, EK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7583-7587
[3]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[4]   A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation [J].
Bonaventura, D ;
Oliveira, FD ;
Togniolo, V ;
Tedesco, AC ;
da Silva, RS ;
Bendhack, LM .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 10 (02) :83-91
[5]   Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol [J].
Borges, ACR ;
Feres, T ;
Vianna, LM ;
Paiva, TB .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) :772-778
[6]   Ca2+-activated K+ channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats [J].
Callera, GE ;
Yogi, A ;
Tostes, RC ;
Rossoni, LV ;
Bendhack, LM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03) :1036-1042
[7]   Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors [J].
Callera, GE ;
Varanda, WA ;
Bendhack, LM .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (06) :379-389
[8]   Changes in the expression and function of arterial potassium channels during hypertension [J].
Cox, RH .
VASCULAR PHARMACOLOGY, 2002, 38 (01) :13-23
[9]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30
[10]   THE NITROVASODILATORS - NEW IDEAS ABOUT OLD DRUGS [J].
HARRISON, DG ;
BATES, JN .
CIRCULATION, 1993, 87 (05) :1461-1467